In addition, we found the CAV1 downregulation is significantly associated with poor prognosis in patients with breast cancer by log rank test in the clinical data from Gene Expression Omnibus (GEO) datasets (GSE1456, 159 patients; GSE3494, 251 patients) (Figures S5A–S5D). The gene discussed is CAV1; the disease is breast cancer.